Egypt explores pharma and healthcare investment with US firm

Egypt’s Ministry of Health has held talks with a US pharmaceutical company to discuss investment in healthcare and drug manufacturing. The meeting aims to attract foreign capital and boost local production capacity.

Health Minister Khaled Abdel Ghaffar met with Lawrence Messick, founder of Pure Peptides Pharmaceutical, to review cooperation opportunities in the Egyptian market.

The discussions focused on pharmaceutical manufacturing, elderly care, and clinical nutrition. Ministry spokesperson Hossam Abdel Ghaffar noted the government’s interest in technology transfer and international expertise.

Abdel Ghaffar invited a company delegation to visit Gypto Pharma city and the Egyptian Drug Authority. The talks form part of efforts to position Egypt as a regional hub for drug production through foreign investment.

Related Articles

Egyptian Health Minister Khaled Abdel Ghaffar urged stronger local pharmaceutical manufacturing to build resilient healthcare supply chains.

Reported by AI

Egyptian Health Minister Khaled Abdel Ghaffar met Kenyan Health Minister Aden Bare Duale on the sidelines of the Global Health Summit in Nairobi to explore expanding cooperation in healthcare and pharmaceuticals. Discussions focused on transferring Egyptian expertise and fast-tracking pending strategic agreements. The initiative underscores Egypt's commitment to continental health security.

Egypt's Ministry of Health is intensifying field inspections and expanding digital oversight of healthcare facilities to improve service quality and efficiency nationwide. Health Minister Khaled Abdel Ghaffar chaired a regular meeting with senior officials to review progress and tackle implementation challenges.

Reported by AI

Egypt’s Minister of Investment and Foreign Trade Mohamed Farid met UK Ambassador Mark Bryson-Richardson to explore ways to expand trade and investment ties between the two countries.

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline